Westfield, IN, United States of America

Christopher T Dennis



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 832,843 
Other
 patents

Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher T. Dennis: Innovator in Immunoassays

Introduction

Christopher T. Dennis is an accomplished inventor based in Westfield, Indiana. With a focus on advancing detection methods in the field of medicine, he has made a significant contribution through his innovative patents.

Latest Patents

Christopher holds a patent for "Immunoassays for everolimus." This patent provides methods for detecting everolimus, a critical drug used primarily in organ transplantation and certain cancers. His invention includes compounds for producing antibodies specific to everolimus, as well as the antibodies produced from these compounds. This development has important implications for improving patient safety and treatment effectiveness.

Career Highlights

Throughout his career, Christopher has dedicated himself to the field of immunology and important biomedical advancements. His patent showcases his ability to blend creativity with scientific knowledge, resulting in practical applications that can enhance healthcare outcomes.

Collaborations

In his professional journey, Christopher has collaborated with notable coworkers such as Mark F. Roberts and Lili Arabshahi. These partnerships have likely fostered an environment of innovation, leading to the development of groundbreaking solutions in the realm of immunoassays and related technologies.

Conclusion

Christopher T. Dennis exemplifies the spirit of innovation through his work in developing immunoassays for everolimus. His contributions are poised to make a significant difference in the medical community, demonstrating the vital role inventors play in shaping future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…